510(k) Report

510(k) · Cleared

Cleared

Passeo 18

K072765510(k) SpecialCleared Dec 12, 200775-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biotronik, Inc. · LIT Catheter, Angioplasty, Peripheral, Transluminal

Cleared on Dec 12, 2007 as substantially equivalent to K033217 (Biotronik, Inc., 2003) and 1 other predicate after a 75-day review. Its family tree reaches back 3 generations to 2000. 7 later devices descend from it.

Decided
Dec 12, 2007
Review
75 days
Class
Class II
Product code
LIT
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K000101 (2000). 6 ancestors in all. 7 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor2001: 2 other ancestors2008: 1 descendant cleared2015: 2 descendants cleared2014: 1 descendant cleared2013: 1 descendant cleared2025: 1 descendant cleared2023: 1 descendant clearedK000101 · RX Viatrac 14 Peripheral Dilatation Catheter · Guidant Corp. · 2000K020854 · Modification to Fox Pta Catheter · Jomed AG · 2002K033217 · Pheron Pta Catheter · Biotronik, Inc. · 2003200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor3 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 3 descendants3 generations forward: 2 descendants K033217 · Pheron Pta Catheter · Biotronik, Inc. · 2003K020854 · Modification to Fox Pta Catheter · Jomed AG · 2002K000101 · RX Viatrac 14 Peripheral Dilatation Catheter · Guidant Corp. · 20000
  1. Root · 3 generations backK000101 RX Viatrac 14 Peripheral Dilatation CatheterGuidant Corp. · 2000
  2. 2 generations backK020854 Modification to Fox Pta CatheterJomed AG · 2002
  3. 1 generation backK033217 Pheron Pta CatheterBiotronik, Inc. · 2003
  4. This deviceK072765 Passeo 18Biotronik, Inc. · 2007
  5. Descendant · cites it directly · 5 of its ownK082933 Passeo-35 Pta CatheterBiotronik, Inc. · 2008
  6. Descendant · 2 generations on · 3 of its ownK142379 Passeo-35 PTA CatheterBiotronik, Inc. · 2014
  7. Descendant · 3 generations on · 1 of its ownK222065 Passeo-35 Xeo Peripheral Dilatation CatheterBiotronik, Inc. · 2023
  8. Descendant · cites it directly · 1 of its ownK151744 Passeo-18 Peripheral Dilation CatheterBiotronik, Inc. · 2015
  9. Descendant · 3 generations on · 1 of its ownK152240 Passeo-14 Peripheral Dilatation CatheterBiotronik, Inc. · 2015

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2008: 12013: 12014: 12015: 22023: 12025: 1
2008high 2 (2015) · low 0 (2009)2026

Most influential descendants

Showing 5 of 7 · See all
  • K082933Passeo-35 Pta CatheterBiotronik, Inc. · 2008 · cites it directly5descendants
  • K142379Passeo-35 PTA CatheterBiotronik, Inc. · 2014 · 2 generations on3descendants
  • K222065Passeo-35 Xeo Peripheral Dilatation CatheterBiotronik, Inc. · 2023 · 3 generations on1descendant
  • K151744Passeo-18 Peripheral Dilation CatheterBiotronik, Inc. · 2015 · cites it directly1descendant
  • K152240Passeo-14 Peripheral Dilatation CatheterBiotronik, Inc. · 2015 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K000101RX Viatrac 14 Peripheral Dilatation CatheterGuidant Corp.2000—
−2K020854Modification to Fox Pta CatheterJomed AG2002—
−1K033217Pheron Pta CatheterBiotronik, Inc.2003—
0 (this device)K072765Passeo 18Biotronik, Inc.2007—
+1K082933Passeo-35 Pta CatheterBiotronik, Inc.2008—
+2K142379Passeo-35 PTA CatheterBiotronik, Inc.2014—
+3K222065Passeo-35 Xeo Peripheral Dilatation CatheterBiotronik, Inc.2023—
+1K151744Passeo-18 Peripheral Dilation CatheterBiotronik, Inc.2015—
+3K152240Passeo-14 Peripheral Dilatation CatheterBiotronik, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200120
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201310
201410
201520
202310
202510
FIG. 1 — Lineage of K072765, 2000–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIT device

  1. #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K033217Pheron Pta Catheter
Summary page 1
…OTRONIK proposes its Pheron peripheral PTA catheter cleared through the following 510(k) notifications as the predicate device for the Passeo-1 8 PTA Catheter: * K033217, cleared October 31, 2003 * K052757, cleared October 28, 2005 Indication for Use: The Passeo-18 peripheral dilatation cat…
Biotronik, Inc.2003—
*K052757Pheron Peripheral Percutaneous Transluminal Angioplasty (Pta) Catheter
Summary page 1
…atheter cleared through the following 510(k) notifications as the predicate device for the Passeo-1 8 PTA Catheter: * K033217, cleared October 31, 2003 * K052757, cleared October 28, 2005 Indication for Use: The Passeo-18 peripheral dilatation catheter is indicated to dilate stenosis in the…
Biotronik AG2005—

Also cleared against K033217: 1 other device →

What descends from it? (7)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K082933Passeo-35 Pta CatheterBiotronik, Inc.20085
K151744Passeo-18 Peripheral Dilation CatheterBiotronik, Inc.20151

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • None of the 6 ancestors has a recall.
  • Of its descendants, K082933 (Biotronik, Inc., 2008) has gone furthest, with 5 descendants of its own.
  • 1 other device also cites its predicate K033217.

How does its category compare?

All LIT devices

LIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · LIT

3in 2025

2007: 62008: 82009: 72010: 132011: 102012: 192013: 142014: 122015: 192016: 112017: 92018: 62019: 42020: 92021: 42022: 82023: 62024: 62025: 32026 (partial year): 4
2007high 19 (2012) · low 3 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIT

90in 2025

2007: 64 days median2008: 53 days median2009: 29 days median2010: 78 days median2011: 82 days median2012: 29 days median2013: 79 days median2014: 90 days median2015: 112 days median2016: 116 days median2017: 57 days median2018: 118 days median2019: 40 days median2020: 125 days median2021: 61 days median2022: 122 days median2023: 167 days median2024: 43 days median2025: 90 days median2026 (partial year): 205 days median
2007high 205 (2026) · low 29 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIT

1in 2025

2009: 22010: 12013: 2, 2 Class I2014: 32016: 12018: 22019: 32021: 12024: 22025: 1
2007high 3 (2014) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LIT

2,073in 2025

2007: 5772008: 5132009: 6232010: 8092011: 8572012: 1,2772013: 1,2422014: 1,1782015: 1,2792016: 1,5292017: 2,0812018: 2,1882019: 2,4052020: 2,4432021: 2,4922022: 2,1552023: 1,8072024: 1,9132025: 2,073
2007high 2,492 (2021) · low 513 (2008)2025

MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076640577
20088530513
20097292623
201013781809
201110820857
2012192901,277
201314792 (2)1,242
2014129031,178
20151911201,279
20161111611,529
201795702,081
2018611822,188
201944032,405
2020912502,443
202146112,492
2022812202,155
2023616701,807
202464321,913
202539012,073
202642050—

What is it indicated for?

Passeo-18 is indicated to dilate stenosis in the femoral, popliteal and infrapopliteal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072765: Passeo 18.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K072765

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026